Adaptive Biotechnologies (ADPT) Capital Expenditures Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 27.78% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | -87.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.37% |
| Dec 31, 2025 | -48.96% |
| Sep 30, 2025 | 833.92% |
| Jun 30, 2025 | 13.46% |
| Mar 31, 2025 | -16.68% |
| Dec 31, 2024 | 300.64% |
| Sep 30, 2024 | -1,782.35% |
| Jun 30, 2024 | 26.76% |
| Mar 31, 2024 | -48.32% |
| Dec 31, 2023 | 94.86% |
| Sep 30, 2023 | -99.69% |
| Jun 30, 2023 | -130.11% |
| Mar 31, 2023 | -0.95% |
| Dec 31, 2022 | -230.75% |
| Sep 30, 2022 | -62.84% |
| Jun 30, 2022 | -82.03% |
| Mar 31, 2022 | -61.65% |
| Dec 31, 2021 | -1.33% |
| Sep 30, 2021 | 89.93% |
| Jun 30, 2021 | 2,621.73% |